Tabiliran, Flor .
HRN: 28-26-57 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2025
CEFUROXIME 500MG (TAB)
12/15/2025
12/22/2025
PO
500mg
BID
S/P NSVD With RMLE
Checking Final Appropriateness